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Abstract 27 
 28 
The product of the hypervariable flaA gene is critical to the motility and 29 
pathogenesis of Campylobacters, making flaA a popular marker for 30 
Campylobacter genotyping. This study describes the interrogation of the flaA 31 
gene using the emerging High Resolution Melting (HRM) technology. HRM is a 32 
single step, closed tube method and the data obtained are portable. A primer 33 
set specific to flaA was selected to ensure that no flaB derived sequences were 34 
amplified in the 620 bp amplicon. The flaA HRM technique was used to type 87 35 
C. jejuni and 15 C. coli isolates from chickens in South East Queensland, 36 
Australia and 47 different HRM profiles were identified. Sequencing was used 37 
to validate the HRM results and it was found that HRM was 100% successful in 38 
discriminating the 47 sequence variants. The flaA HRM results correlated with 39 
the known epidemiological history of the isolates and the resolving power of 40 
the method was multiplicative to that of CRISPR HRM. Thus, flaA HRM is a 41 
rapid, cheap and convenient alternative to currently available Campylobacter 42 
flaA typing schemes and can be used as a first pass genotyping method in 43 
epidemiological studies. 44 
45 
 3
INTRODUCTION 46 
 47 
Campylobacter jejuni and Campylobacter coli are the most common causes 48 
of human bacterial gastroenteritis in industrialised countries (21). The flagellin 49 
encoding genes flaA and flaB share 95% sequence homology, and are arranged in 50 
tandem (9, 20). While flaA gene expression appears critical for motility, colonisation 51 
and pathogenesis, this is not the case for flaB, which is thought to be a largely non-52 
functional reservoir of genetic variation that can increase the diversity of flaA by 53 
recombination, and so assist the cell evade host immune responses (1, 7, 8, 28). 54 
 55 
The flaA gene is commonly used for typing C. jejuni and C. coli. Two methods 56 
have gained wide acceptance: flaA restriction fragment length polymorphism (RFLP) 57 
(19) and flaA Short Variable Region (SVR) sequencing (16). The flaA RFLP 58 
technique involves PCR amplification of the entire flaA gene followed by RFLP of the 59 
PCR product (19). Sequencing the SVR of the flaA gene was developed as more 60 
streamlined and portable alternative to flaA RFLP protocols (16), and sequence 61 
variants are compiled at a central website 62 
(http://pubmlst.org/perl/mlstdbnet/agdbnet.pl?file=flaA.xml) (10). While both of these 63 
methods are very effective, they have several disadvantages: the RFLP approach is 64 
multi-step, because the PCR product must be cleaved with a restriction enzyme, and 65 
the fragments subsequently resolved by electrophoresis (33). Also, there are many 66 
changes in the sequence that will not alter the sizes of the restriction fragments. SVR 67 
sequencing is also multistep, the targeted region is small which limits resolving 68 
power, and DNA sequencing requires expensive equipment in specialised facilities  69 
(6). 70 
 71 
High Resolution Melting (HRM) analysis is an emerging method that has been 72 
applied to the interrogation of single nucleotide polymorphisms (SNPs), hypervariable 73 
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repeat regions in PCR products and also the discovery of new SNPs (3, 24, 26, 27, 74 
30). It is based upon the accurate monitoring of the reduction in fluorescence as a 75 
PCR product stained with a double-strand specific fluorescent dye is heated through 76 
its melting temperature (Tm). In contrast to traditional melting analysis, the 77 
information in HRM analysis is contained in the shape of the melting curve, rather 78 
than just the calculated Tm, so HRM analysis may be considered a form of 79 
spectroscopy. HRM analysis is single step and closed tube, because the 80 
amplification and melting can be run as a single protocol on a real-time PCR device.   81 
 82 
Our group has an ongoing interest in the use of HRM to interrogate loci with 83 
complex variation (23, 24, 27), and has previously reported an HRM-based method 84 
for interrogating the C. jejuni CRISPR locus (24). The purpose of this study was to 85 
develop a C. jejuni/C. coli typing method based on HRM analysis of flaA.   86 
 87 
MATERIALS AND METHODS 88 
 89 
Isolates and DNA extraction. Eighty-seven C. jejuni and 15 C. coli isolates were 90 
used in this study. The C. jejuni  isolates have been previously described (17). They 91 
were all obtained from the chickens in South-East Queensland, Australia. The 92 
collection contained three groups of ten C. jejuni isolates that were termed L1 and L2 93 
and L3. The isolates within each group were obtained at the same time and place, 94 
and a variety of genotyping methods have shown a clonal relationship between the 95 
members of each group (17). The members of each group are therefore regarded as 96 
being epidemiologically linked. The flaA RFLP types of L1, L2 and L3 were FT-XXVI, 97 
FT-I and FT-VII respectively. The remainder of the collection consisted of 26 C. jejuni 98 
isolates that were obtained at different times and/or places, and were selected on the 99 
basis of being FT-I, and 46 isolates (31 C. jejuni and 15 C. coli) that were selected on 100 
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the basis that each possessed a different flaA RFLP type. More detailed descriptions 101 
of these isolates are available as supplementary data.  102 
 103 
Genomic DNA was extracted using the DNeasy Blood and Tissue Lysis kit as 104 
per manufacturer’s instructions (Qiagen, Clifton Hill, 133 Australia).   105 
 106 
HRM protocol for flaA and CRISPR interrogation. All the HRM analyses were 107 
performed on a Corbett Rotor-Gene 6000 (Corbett Research, Sydney, Australia). 108 
Due to a corporate acquisition, the Corbett Rotor-Gene 6000 instrument is no longer 109 
available, but the QIAGEN Rotorgene Q with HRM capability is an essentially 110 
identical device.     111 
 112 
The flaA HRM analysis method developed in the course of this study was as 113 
follows: DNA was amplified using primers flaA4f and flaA625RU (16). The 10 µL 114 
reactions comprised of 5 µl of Platinum® SYBR® Green qPCR SuperMix-UDG 115 
(Invitrogen Australia, Mulgrave, Victoria), 5pmol of each primer, 1 µl of template and 116 
3.5 µl of H2O. The cycling conditions were 95°C for 2 min, 40 cycles of 95°C for 30 117 
seconds, 59°C for 20 seconds and 72°C for 45 seconds, followed by 72°C for 2 min 118 
and 50°C for 2 min. The amplified DNA was then subjected to HRM with 0.05°C 119 
increments in temperature ranging from 72°C to 84°C. The HRM curves were 120 
normalised using the sections of the raw fluorescence data from 72.6°C to 73.2°C 121 
and from 82.8°C to 83.2°C. The reference isolate NCTC11168 was included in each 122 
run as a control to monitor inter-run variability. The reactions were routinely carried 123 
out in duplicate.   124 
 125 
CRISPR interrogation was performed as previously described (24). The 126 
different melting profiles assigned were called CRISPR types (CTs). 127 
 6
 128 
Analysis of HRM data.  Three different strategies were used to estimate whether 129 
pairs of HRM curves were derived from the same or different sequences.   Firstly, in 130 
many cases HRM curves could be discriminated on the basis of obvious differences 131 
in curve shape, and/or on the basis of Tm, with a difference of 0.2 °C regarded as 132 
significant. Secondly, we have previously reported using difference graph analysis, 133 
with an amplitude of >5 normalised fluorescence units being indicative that the base-134 
line curve and the ‘comparator’ curve arose from different sequences (24).  Finally, 135 
we used an approach similar to that described by Andersson et al. (2). This is a 136 
development of the difference graph-based method, and involves deriving the 3rd and 137 
97th centiles from the mean ± 1.96 standard deviations for the fluorescence at every 138 
temperature. This generates 3rd and 97th centile curves analogous to those used to 139 
monitor growth in children. Andersson et al (2) termed these “confidence limits”, but 140 
we now believe that the term “3rd and 97th centile curves” is more technically correct. 141 
3rd and 97th centile curves were calculated from at least nine replicates. Both 142 
normalised fluorescence and dF/dT data were used.   143 
 144 
The Rotor-Gene 6000 software versions 1.7.34 or 1.7.87 were used to 145 
analyse HRM data within a run, while exported data was analysed using either 146 
Teechart Office 2.0 or Microsoft Excel 2003.  147 
 148 
DNA Sequencing. PCR products ranging in amount from 25-35 ng with 6.4 pmol of 149 
primers were submitted for sequencing to the Australian Genome Research Facility 150 
(AGRF), Brisbane, Australia.  151 
 152 
 153 
 154 
 155 
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RESULTS 156 
 157 
Identification of a flaA fragment suitable for HRM analysis. Defining a flaA 158 
fragment suitable for HRM analysis was a compromise between minimising the size 159 
of the fragment in order to simplify the discrimination of alleles, and maximising the 160 
size of the fragment so as to maximise the number of alleles and consequent 161 
resolving power. An additional factor was the presence of flaB which is very similar to 162 
flaA. A mixed PCR fragment that is derived from both flaA and flaB would be 163 
essentially impossible to analyse meaningfully by HRM, so it was regarded as 164 
essential to ensure that the primer set was flaA  specific.  165 
 166 
Initial experiments were carried out using the PCR fragment that is commonly 167 
used for flaA SVR sequence typing. This was amplified by primers flaA242FU and 168 
flaA625RU (Fig.1). Sequence analysis revealed significant numbers of double peaks. 169 
This was probably caused by the presence of the flaB-derived sequence in the PCR 170 
product (data not shown). It was concluded that this primer set was unsuitable for 171 
flaA HRM analysis.  172 
 173 
The next primer set to be tested incorporated the upstream primer used for 174 
flaA RFLP analysis (flaA4F), and the downstream primer used for SVR sequence 175 
analysis (flaA625RU) (Fig. 1). Amplification and sequencing of this fragment from 176 
three isolates (one isolate from each of the three epidemiologically linked groups L1, 177 
L2 and L3) yielded sequence traces with no double peaks, indicating that there was 178 
no significant contamination with flaB derived sequences. It was concluded that this 179 
620 bp fragment was promising for HRM-based genotyping.  180 
 181 
HRM analyses. HRM analysis of the 620 bp fragment was carried out for all isolates. 182 
The analyses were performed prior to sequence determination, for all isolates except 183 
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the three used for the validation of the 620 bp fragment that was described in the 184 
previous section.   185 
 186 
The HRM curves were compared on the basis of shape and Tm, and in some 187 
instances, difference graphs were used (see Methods). Based on these analyses, it 188 
was estimated that there were likely to be 47 sequence variants. A sample of HRM 189 
curves are shown in Fig. 2 and all curves are provided as supplementary data. The 190 
different melting curves were named flaA HRM type (FHT)-1 to FHT-47.  191 
 192 
After sequence analysis had been carried out, it was found that the HRM 193 
analyses had been completely successful in resolving all the sequence variants, and 194 
there were no occasions when HRM curves derived from identical sequences had 195 
been classified as different. In other words, the HRM analysis was 100% in accord 196 
with the sequence-based gold standard. The sequences also confirmed that the flaA 197 
HRM amplification primers generated product not contaminated with flaB or any other 198 
sequence.  The sequences have been deposited in the flaA SVR sequence database 199 
and in Genbank under accession numbers…………  200 
 201 
In order to increase the sophistication of our HRM data analysis methods, the 202 
FHT-1 and FHT-2 HRM curves were further analysed. The data for this was obtained 203 
by analysing in duplicate ten isolates with these genotypes. FHT-1 and FHT-2 were 204 
chosen because the HRM curves are very similar.   The results are shown in Fig 3. In 205 
Fig 3A, it can be seen that there is a visible, albeit subtle, difference between the 206 
normalised FHT-1 and FHT-2 curves. Fig 3B shows that difference graph analysis 207 
normalised using an FHT-1 HRM curve does appear to divide the FHT-1 and FHT-2 208 
curves into two groups. However, there is some variation within the two genotypes. 209 
Also, the FHT-2 difference graphs do not reach ±5. An amplitude of 5 is one of the 210 
criteria previously used to call a difference graph as being derived from a sequence 211 
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that is different to the one that defines the base-line (24).  In other words, the 212 
difference graph was not clearly indicating sequence variation. However, Fig 3C 213 
shows that the dF/dT curves for both FHTs consist of two peaks, and that there 214 
appears to be a consistent difference between the FHT-1 and FHT-2 curves that is 215 
manifested as the position of the small peak.  Fig 3D depicts the 3rd and 97th centile 216 
curves (see Materials and Methods) (black lines) for the dF/dT of the FHT-1 HRM 217 
curve. These were calculated from the 10 isolates that belong to the 218 
epidemiologically linked group L2.  A typical FHT-2 dF/dT curve is shown (grey), and 219 
as expected a substantial portion of the small peak is outside the 3rd and 97th centile 220 
curves. Interestingly, the amplitude of the FHT-2 large peak is also outside the FHT-1 221 
3rd and 97th centile curves, suggesting a subtle but consistent difference in the slope 222 
of the normalised curves at temperatures close to the Tm.  223 
 224 
Correlation of flaA HRM with flaA SVR sequence analysis and flaA RFLP.  The 225 
fragment of the flaA gene interrogated by HRM includes the SVR and 238 base pairs 226 
upstream of the SVR (Fig. 1). HRM, therefore, has the potential to split single SVR 227 
sequence types. We found one such examples in our dataset: Two isolates with the 228 
same flaA SVR allele (allele 117), were resolved by HRM into two different HRM 229 
types (FHT-10 and FHT-44), which are discriminated from each other by two SNPs 230 
upstream of the SVR.  231 
 232 
The flaA RFLP method involves the amplification and restriction profiling of 233 
the entire flaA gene (1.7kb) (Fig.1). The flaA RFLP fragment is thus larger than the 234 
HRM fragment and will contain more polymorphisms. However, not all 235 
polymorphisms may occur within restriction sites, so an identical restriction profile 236 
may be observed across sequence variants. Therefore, it is an interesting question 237 
as to whether flaA RFLP or flaA HRM will provide the higher resolution. Our results 238 
showed that FT-I, comprising 36 isolates was resolved into five HRM types (FHT-1, 239 
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2, 3, 13 and 47). However, there were six instances (FHT-3, 5, 13, 21, 23 and 42) 240 
where HRM was unable to resolve the different FTs (FT-I and XXV, FT-XLVI and XV, 241 
FT-I and IV, FT-LXI and XI, FT-VIII and LIX and FT-LV and LXII).  242 
 243 
The resolving power of flaA HRM analysis is multiplicative to the resolving 244 
power of CRISPR HRM analysis. Our research group has previously reported the 245 
application of HRM to the interrogation of the highly variable C. jejuni CRISPR locus 246 
(24).  It would be expected that the combinatorial resolving power of CRISPR HRM 247 
and fla HRM would be greater than either method on its own, particularly given the 248 
high recombination rate of C. jejuni (5, 28, 34). Isolates were selected for this study 249 
on the basis of flaA RFLP type, and included a substantial collection of 250 
epidemiologically unlinked flaA RFLP type I isolates, and another set that were all 251 
chosen to be different with respect to flaA RFLP. This precluded direct comparisons 252 
of the resolving powers of the two HRM methods alone or in combination.  However, 253 
we were able to observe that FHT-2, which represents the majority of the 254 
epidemiologically unlinked FT-I isolates was resolved into nine CRISPR HRM types, 255 
thus demonstrating the potential of CRISPR HRM to subdivide FHTs.   256 
 257 
The C. jejuni isolates included in this study have previously been subjected to 258 
typing based on resolution optimised SNPs derived from the C. jejuni/C. coli MLST 259 
database, and resolution optimised binary markers derived from micro-array data 260 
(17) The results of all the typing methods from this and previous studies have been 261 
collated and are supplied as supplementary data.  As expected, none of the typing 262 
methods divide the isolates into exactly the same groups, so the resolving powers of 263 
all are multiplicative, with the qualification that in this study, SVR sequencing did not 264 
resolve any flaA HRM types.   265 
 266 
 267 
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DISCUSSION 268 
 269 
The flagellin gene has been a well accepted marker for Campylobacter 270 
genotyping for over two decades (4, 16, 18, 19, 22, 25, 32). In this study we have 271 
developed a genotyping method based on flaA interrogation using HRM analysis. 272 
The procedure is single step and closed tube, takes approximately three hours to 273 
perform, and costs approximately US$1.00. 274 
 275 
One unusual aspect of this study is the large size of the fragment (620 bp) 276 
that we able to successfully analyse using HRM. HRM is usually applied to the 277 
analysis of single SNPs in much smaller fragments (13-15, 29). The ability of HRM to 278 
correctly resolve the 47 flaA 620 bp fragment alleles included in this study was 279 
somewhat unexpected. It would not be appropriate to extrapolate from this to 280 
conclude that HRM can detect any change in this sequence. However, it does 281 
suggest that this method could effectively replace either flaA RFLP or SVR 282 
sequencing as a first pass technique for testing hypotheses regarding 283 
epidemiological linkage.   284 
 285 
It is desirable that any bacterial typing method yield data that is easily 286 
portable between laboratories. The successful comparison of HRM data between 287 
runs and between different devices has recently been reported (27, 31) Our 288 
experience with the Corbett Rotor-Gene 6000 is that the relative temperature 289 
calibration is extremely accurate, but that the absolute calibration can vary by up to 290 
0.5° C between different instruments. This means that the shape of the HRM curve is 291 
completely consistent from device to device, but temperature normalisation may 292 
sometimes be necessary. This could easily be achieved by including a control 293 
sequence with a known Tm in any batch of HRM analyses. The portability of the 294 
HRM data raises the possibility of on-line libraries of high resolution melting curves, 295 
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that ideally would include centile curves or analogous descriptors of variation, and 296 
applications for carrying out temperature normalisation and searches for similar 297 
curves.   298 
 299 
In this study, the FHT-1 and FHT-2 curves were used as a model system to 300 
further explore HRM curve comparison strategies. In the case of FHT-1 and FHT-2, 301 
the presence of a second peak assisted greatly in discrimination. We were 302 
concerned that this peak may have arisen from a secondary PCR product, but this 303 
was never visible on any electrophoresis gel (data not shown), and the relative 304 
amplitudes of the large and small peak were highly consistent. This suggests that the 305 
presence of two peaks is a function of different melting domains within the same 306 
sequence. In a sequence of 620 bp, this is plausible. For these curves, inspection of 307 
the dF/dT curves was the most effective means of discrimination, and consistent 308 
difference between FHT-1 and FHT-2 was confirmed by calculating the FHT-1 dF/dT 309 
3rd and 97th centile curves.   310 
 311 
The isolates included in this study have been subjected to typing on the basis 312 
of variation in resolution optimised MLST-database derived SNPs, and resolution 313 
optimised binary markers (17) as well as the methods addressed in the present 314 
study. The SNP, binary marker, and HRM based methods can all be performed on 315 
the real-time PCR platform and they all yield digitisable results (17, 23-25), thus 316 
providing a readily accessible choice of methods or combinations of methods that 317 
can be adapted to different tasks and questions. It has previously been shown that 318 
the resolution optimised SNPs defined genotypes correlate well with the MLST-319 
defined population structure i.e. there was a strong tendency for isolates with 320 
identical SNP types to have identical or very similar MLSTs (25). It was also found 321 
that addition of flaA SVR sequencing resulted in the correlation between genotype 322 
and population structure becoming essentially perfect (25). The present study 323 
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suggests that SVR sequencing could be replaced with flaA HRM analysis, and that a 324 
combination of the SNP-based typing and flaA HRM analysis, both of which can be 325 
carried out on a real-time PCR machine, would provide both an indication of the 326 
evolutionary position of the genome backbone, and good resolution. CRISPR HRM 327 
and binary marker-based typing would be expected to add yet more resolving power. 328 
The strategy of using selected SNPs in combination with markers that may evolve 329 
more rapidly is reminiscent of the Phylogenetic Hierarchical Assays using Nucleic 330 
Acids (PHRANA) strategy articulated by Keim and co-workers (11, 12) who have 331 
applied it to the large scale reconstruction of anthrax epidemiology. The performance 332 
of these real-time PCR-based typing methods will not equal the performance of 333 
whole genome sequence analysis, high density array-based methods, or the 334 
interrogation of large numbers of SNPs. However, real-time PCR is ideal for 335 
immediate closed-tube analysis of samples at locations away from large laboratories.  336 
 337 
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LIST OF FIGURES 468 
 469 
Fig 1. The flaA fragments used in RFLP, SVR sequencing and HRM-based 470 
genotyping. The PCR primers are depicted by the small arrows.  471 
 472 
Fig 2. Examples of normalised HRM curves and their reproducibility. These 473 
are derived from 10 isolates of each of the three epidemiologically linked groups L1 474 
(light grey), L2 (black), L3 (dark grey). One DNA preparation from each isolate was 475 
assayed in duplicate. The “replicate view” option was used, so each curve is the 476 
mean of the data from the duplicates.  477 
 478 
Fig 3. Detailed comparison of the FHT-1 and FHT-2 HRM curves. A. 479 
Magnified portion of replicate FHT-1 (black) and FHT-2 (grey) normalised HRM 480 
curves. B.  Difference graph depicting FHT-1 (black) and FHT-2 (grey). Data from a 481 
randomly chosen FHT-1 isolate was used as the X-axis (C) Comparison of the dF/dT 482 
curves for replicates of FHT-1 (black) and FHT-2 (grey). D. 95% 3rd and 97th centile 483 
curves for the dF/dT curve for FHT-1 (black), and a typical FHT-2 curve (grey).   484 
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Supplementary Table 1:  Results of the various real-time PCR and HRM based methods used to type the chicken C. jejuni and C. coli isolates 
Isolate Species Source FlaA RFLP^ SNP Type* Binary type* CRISPR type 
SVR sequence 
type flaA HRM type 
C838 C. jejuni Dropping I 2 16 2 46 1 
C916 C. jejuni Dropping I 2 30 2 46 1 
H25 C. jejuni Dropping I 2 30 2 46 1 
J185 C. jejuni Dropping I 2 30 2 46 1 
L2# C. jejuni Droppings I 2 30 2 46 1 
C1267 C. jejuni Dropping I 5 25 13 9 2 
C354 C. jejuni Dropping I 2 30 10 9 2 
C475 C. jejuni Dropping I 30 26 6 9 2 
C488 C. jejuni Dropping I 2 30 14 9 2 
C495 C. jejuni Dropping I 2 30 10 9 2 
C586 C. jejuni Dropping I 2 30 10 9 2 
C607 C. jejuni Dropping I 5 21 9 9 2 
C612 C. jejuni Dropping I 2 30 10 9 2 
C628 C. jejuni Dropping I 36 30 10 9 2 
C656 C. jejuni Dropping I 5 21 9 9 2 
C729 C. jejuni Dropping I 5 21 9 9 2 
DAQ282A-1123 C. jejuni Biosecurity Studies I 37 26 6 9 2 
DAQ282A-190 C. jejuni Crate - 3d I 37 39 6 9 2 
DAQ282A-263 C. jejuni Crate - 1e I 23 21 9 9 2 
G141 C. jejuni Dropping I 5 25 15 9 2 
L176 C. jejuni Dropping I 5 21 16 9 2 
M2 C. jejuni Dropping I 5 14 17 9 2 
P2 C. jejuni Dropping I 34 21 18 9 2 
C1274 C. jejuni Dropping XXV 4 40 37 103 3 
K35 C. jejuni Dropping I 5 50 5 103 3 
C1275 C. jejuni Crates XXVII 12 49 38 162 4 
C1288 C. coli Dropping XLVI 24 35 N/A 34 5 
C350 C. jejuni Dropping XV 29 44 32 34 5 
C338 C. jejuni Dropping XIV 15 16 39 18 6 
C1212 C. jejuni Dropping V 12 14 23 57 7 
C1266 C. jejuni Dropping XVII 6 45 33 419 8 
C576 C. jejuni Dropping XIII 31 7 29 49 9 
C1209 C. jejuni Dropping III 28 42 19 117 10 
C286 C. coli Dropping XXXVII 24 53 N/A 30 11 
C326 C. coli Dropping XXXVI 24 35 N/A 325 12 
C1211 C. jejuni Dropping IV 29 17 3 1067 13 
C1214 C. jejuni Dropping I 35 48 12 1067 13 
C1218 C. coli Dropping XXXV 42 51 N/A 1068 14 
C1269 C. jejuni Dropping XVIII 35 18 10 67 15 
C1270 C. jejuni Dropping XXIII 22 17 35 787 16 
C1273 C. jejuni Dropping XXIV 13 41 36 42 17 
C1282 C. jejuni Dropping XXII 6 46 7 5 18 
C1287 C. coli Dropping XLV 24 54 N/A 1093 19 
C654 C. jejuni Dropping X 11 16 26 21 20 
C660 C. jejuni Dropping XI 14 15 27 16 21 
DAQ282A-898 C. jejuni Dropping LXI 15 15 22 16 21 
C674 C. jejuni Dropping IX 6 17 20 22 22 
C858 C. jejuni Dropping VIII 11 30 25 36 23 
DAQ282A-861 C. coli Dropping LIX 43 52 N/A 36 23 
L3# C. jejuni Dropping VIII 5 21 3 36 23 
C915 C. jejuni Dropping VII 1 2 1 1160 24 
DAQ282A-639 C. jejuni Dropping XLVII 32 20 31 1094 25 
DAQ282A-669 C. coli Dropping LVII 42 51 N/A 1096 26 
DAQ282A-698 C. jejuni Larvae - 1e XLVIII 33 17 8 15 27 
DAQ282A-707 C. coli Dropping L 41 51 N/A 1096 28 
DAQ282A-712 C. coli Dropping LI 42 51 N/A 1097 29 
DAQ282A-726 C. coli Dropping LII 24 54 N/A 1040 30 
DAQ282A-769 C. coli Dropping LIV 24 54 N/A 1006 31 
N15 C. jejuni Dropping LIII (XXIV) 6 17 1 2 32 
C1276 C. jejuni Dropping XXVI 1 1 1 14 33 
L1# C. jejuni Dropping XXVI 1 1 1 14 33 
DAQ282A-909 C. jejuni Dropping I 11 38 9 9 34 
C1208 C. jejuni Dropping II 3 2 1 10 35 
C541 C. jejuni Dropping XVI 21 31 7 54 36 
C775 C. jejuni Dropping XX 5 21 1 11 37 
C943 C. coli Dropping XXXI 24 35 N/A 311 38 
C964 C. coli Crate XXX 41 36 N/A 1098 39 
C1272 C. jejuni Dropping XIX 28 43 30 239 40 
DAQ282A-921 C. jejuni Dropping LVI 22 31 21 396 41 
DAQ282A-596 C. coli Beetles - 5/6e LXII 24 35 N/A 467 42 
DAQ282A-912 C. coli Dropping LV 40 35 N/A 467 42 
C1210 C. jejuni Dropping VI 38 47 24 1066 43 
C1271 C. jejuni Dropping XXI 18 31 34 117 44 
C627 C. jejuni Dropping XII 22 37 28 190 45 
C1280 C. coli Dropping XXXIV 44 51 N/A 1008 46 
C734 C. jejuni Dropping I 4 8 11 423 47 
 
# L1, L2 and L3: Three groups of ten epidemiologically linked isolates (n=10 within each group) 
^ Performed previously by Miflin et al., (18) 
* Incorporated from Merchant-Patel et al., (17) 
 
